Palazestrant
Product Specifications
CAS Number
2092925-89-6
Synonyms
OP-1250
Target
Estrogen/progestogen Receptor
Applications
Endocrinology & Hormones
Molecular Formula
C28H36FN3O
Additionnal Information
Palazestrant (OP-1250) is an orally bioavailable complete antagonist of estrogen receptor (ER) that blocks ER activity. It exhibits antiproliferative and antitumor activity in ER-positive (ER+) breast cancer models.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1378297-01 0.02 mg (E-Coli)
Recombinant Naja atra Cytotoxin Clbp-3
Sign In for Pricing
View Details MBS1378297-02 0.1 mg (E-Coli)
Recombinant Naja atra Cytotoxin Clbp-3
Sign In for Pricing
View Details MBS1378297-03 0.02 mg (Yeast)
Recombinant Naja atra Cytotoxin Clbp-3
Sign In for Pricing
View Details MBS1378297-04 0.1 mg (Yeast)
Recombinant Naja atra Cytotoxin Clbp-3
Sign In for Pricing
View Details